Elevated interleukin-32 expression in granulomatosis with polyangiitis

Rheumatology (Oxford). 2012 Nov;51(11):1979-88. doi: 10.1093/rheumatology/kes163. Epub 2012 Jul 31.

Abstract

Objective: To evaluate the role of IL-32 in granulomatosis with polyangiitis (GPA) patients and the relationship between IL-32 and disease activity, as PR3 has the ability to bind and activate IL-32, which has been described as a novel cytokine that induces inflammatory cytokines.

Methods: We investigated the level of IL-32, PR3, TNF-α and IL-6 in GPA patients by using ELISA. Northern blot was used to analyse the level of IL-32 mRNA in leucocytes of GPA patients. The intracellular colocalization of IL-32 and PR3 in leucocytes was examined by IF staining.

Results: We observed that IL-32 and PR3 levels in GPA patients were increased significantly when compared with normal individuals and each was tightly associated (P < 0.001). Northern blot analysis revealed that the mRNA level of IL-32 was prominently elevated in leucocytes of GPA patients. The intracellular colocalization of IL-32 and PR3 in leucocytes from GPA patients vs normal individuals was verified by IF staining.

Conclusion: IL-32 level was elevated in GPA patients but its level was changed by treatment response. IL-32 could be an index in GPA and play a role in the aetiology of GPA.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Blotting, Northern
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Granulomatosis with Polyangiitis / etiology*
  • Granulomatosis with Polyangiitis / metabolism
  • Humans
  • Interleukin-6 / metabolism
  • Interleukins / metabolism
  • Interleukins / physiology*
  • Leukocytes / metabolism
  • Male
  • Middle Aged
  • Myeloblastin / metabolism
  • RNA, Messenger / metabolism
  • Tumor Necrosis Factor-alpha / metabolism
  • Vasculitis / etiology
  • Vasculitis / metabolism

Substances

  • IL32 protein, human
  • Interleukin-6
  • Interleukins
  • RNA, Messenger
  • Tumor Necrosis Factor-alpha
  • Myeloblastin